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Background: The γ-aminobutyric acid (GABA) type A receptor (GABAAR) contains the recognition sites for a variety
of agents used in the treatment of brain disorders, including anxiety and epilepsy. A better understanding of how
receptor expression is regulated in individual neurons may provide novel opportunities for therapeutic intervention.
Towards this goal we have studied transcription of a GABAAR subunit gene (GABRB1) whose activity is autologously
regulated by GABA via a 10 base pair initiator-like element (β1-INR).
Methods: By screening a human cDNA brain library with a yeast one-hybrid assay, the Polycomblike (PCL) gene
product PHD finger protein transcript b (PHF1b) was identified as a β1-INR associated protein. Promoter/reporter
assays in primary rat cortical cells demonstrate that PHF1b is an activator at GABRB1, and chromatin
immunoprecipitation assays reveal that presence of PHF1 at endogenous Gabrb1 is regulated by GABAAR activation.
Results: PCL is a member of the Polycomb group required for correct spatial expression of homeotic genes in
Drosophila. We now show that PHF1b recognition of β1-INR is dependent on a plant homeodomain, an adjacent
helix-loop-helix, and short glycine rich motif. In neurons, it co-immunoprecipitates with SUZ12, a key component of
the Polycomb Repressive Complex 2 (PRC2) that regulates a number of important cellular processes, including gene
silencing via histone H3 lysine 27 trimethylation (H3K27me3).
Conclusions: The observation that chronic exposure to GABA reduces PHF1 binding and H3K27 monomethylation,
which is associated with transcriptional activation, strongly suggests that PHF1b may be a molecular transducer of
GABAAR function and thus GABA-mediated neurotransmission in the central nervous system.Background
The γ-aminobutyric acid (GABA) type A receptor
(GABAAR) plays a critical role in the pathophysiology of
brain disorders such as anxiety and epilepsy, presenting
an important therapeutic target for research. Of particu-
lar interest is the mechanism that underlies the expres-
sion of eight distinct GABAAR subunit classes whose
collection of genes are differentially transcribed to form
diverse receptor subtypes, with variable affinities for acti-
vation and modulation [1]. Variations in receptor sub-
unit composition are also associated with different
disease states. For instance, pilocarpine induces status
epilepticus (SE) and spontaneous seizures in rats that
are accompanied by a decrease in α1 and β1 subunit* Correspondence: srussek@bu.edu
†Equal contributors
2Department of Pharmacology & Experimental Therapeutics, Laboratory of
Translational Epilepsy, Boston University School of Medicine, 72 East Concord
Street, Boston, MA 02118, USA
Full list of author information is available at the end of the article
© 2013 Saha et al.; licensee BioMed Central Lt
Commons Attribution License (http://creativec
reproduction in any medium, provided the ormRNAs, and a marked increase in α4 [2]. Recent reports
using chromatin immunoprecipitation (ChIP) assays of
primary neurons and slices of dentate gyrus from ani-
mals 24 hours after SE have shown that levels of these
GABAA receptor subunits may be regulated by changes
in transcription that are driven by activity-dependent
transcription factors [3-6].
Most interesting to the study of GABAAR regulation is
the fact that chronic activation leads to an associated de-
crease in the levels of particular GABAAR subunit
mRNAs, their cognate proteins, and their promoter/re-
porter activity, as measured in primary cultured neurons
and in vivo. While it is certainly well established that the
majority of genes rely on upstream regulatory elements
to control relevant levels of gene expression, our previ-
ous studies showed that an initiator (β1initiator element
[INR]; a 10 base pair (bp) core sequence that contains
the transcriptional start site of GABRB1) is critical for
the expression of β1 subunit mRNAs in neocortical andd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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most of the GABRB1 promoter (GABRB1-p) reveals that
the initiator is indispensable for neuron-specific promoter
activity that is autologously regulated (transcriptionally re-
pressed after chronic GABAAR activation). Replacing the
core GABRB1-p with three concatenated copies of the
β1-INR reconstitutes full promoter/reporter activity that is
both neural-specific and autologously regulated.
Transcriptional regulators function through DNA-
protein or protein-protein interactions that regulate the
recruitment and assembly of the pre-initiation complex
(PIC), which contains RNA polymerase II and general
transcription factors (GTFs), TFIID, B, A, E, F and H
[8-11]. The TATA box is located nearly −30 nucleotides
upstream of the transcription start site and directs the
initiation of transcription and assembly of the general
transcription apparatus [12]. The downstream INR con-
tributes to start site selection and directs the transcrip-
tional initiation of genes with non-canonical TATA
boxes [13]. Although a number of INRs have been iden-
tified among mammalian genes, the initiator binding
complex is poorly understood. RNA polymerase II rec-
ognizes core promoter sequences to influence start site
selection at the core promoter [14,15]. TAFII250 and
TAFII150 (TAFs 1 and 2) [16] contribute to the selective
recognition of promoters containing INRs [17-21]. A
number of transcriptional regulators such as TFII-I, E2F,
YY1 and USF stimulate transcription by binding to sites
that overlap core promoter sequences [12,22]. Specific
INR-binding proteins like YY1 and TFII-I contain dis-
tinct motifs for DNA binding [23-25]. YY1 binds
through two zinc finger (C2H2) domains [26] whereas
TFII-I, a context-dependent DNA recognition protein,
binds through multiple helix-loop-helix (HLH) motifs
with the aid of a basic rich region [24].
Chromatin remodeling plays an important role in either
facilitating or preventing RNA polymerase II access to
promoter regions, targeting N-terminal histone tails for
acetylation, methylation, phosphorylation and/or ubiquti-
nation modification(s) [27-30]. Two groups of proteins are
found to be involved in regulating the modification status
of chromatin at promoter regions: Trithorax (trxG) and
Polycomb-Group (PcG) proteins. Both protein groups
maintain active and silent status of transcriptional activity,
respectively [31,32]. PcG proteins are encoded by some 40
genes in Drosophila, which include Polycomb (PC),
Polyhomeotic (PHO), Polycomblike (PCL) and Posterior
sex comb (PSC). PcG proteins maintain promoters in an
inactive state, whereas trxG proteins counteract silencing
by stimulating transcription [28,32-34]. Recently, two
main Polycomb groups of repressive complexes have been
characterized: PRC1 and PRC2, which appear to form bio-
chemically distinct repressive units. Four core components
of PRC2 are EZH2, SUZ12, EED and RbAp46/48 [32] andeach protein in the complex has a distinct functional role
in silencing transcriptional activity.
In this paper, we now show that PHF1b, a Polycomblike
protein, binds to the β1-INR to stimulate transcription. In
addition, our results demonstrate that chronic GABA
treatment reduces the presence of PHF and monome-
thylated histone H3 lysine 27 (H3K27) at endogenous rat
Gabrb1-p, consistent with a role for PHF1b in remodeling
the local chromatin environment of the core promoter
region in response to neuronal signals.
Results
Isolation of a cDNA encoding an initiator-associated protein
To further understand neural-specific expression of
GABRB1-p [7], we cloned the factor that associates with
the β1-INR. A one-hybrid screen was performed using a
transformed S. cerevisiae strain (Figure 1A, top panel) that
included two chromosomally integrated reporters and a
human neonatal or adult brain cDNA library. Each re-
porter gene (His3 and LacZ) was regulated by three tan-
dem repeats of the β1-INR, a configuration shown to
reconstitute neuronal specificity and autologous regulation
of GABRB1 [7]. In a parallel experiment, nonselective
media containing no aminotriazole was used to make sure
that enough yeast transformants were obtained to cover
the complexity of the cDNA library.
Five hundred yeast colonies carrying potential candi-
dates were isolated from the His3 screen. These yeast
colonies were further tested for their ability to express
the second reporter LacZ, which yielded 50 candidates
that stimulated both reporters. Only four candidates
(A4, A10, B33, B37) were positive upon retransformation
of isolated clones. DNA sequencing and blast analysis
revealed a perfect match of these four clones to a splice
variant (b) of human Polycomblike protein PHF1. The
full length PHF1b sequence in the database (ACC#
BC008834) was compared to that of the isolated clones
(see Figure 1, bottom panel). Candidates B33 and B37
are identical, whereas, candidate A10 is 10 amino acids
longer than either B33 or B37. Candidate A4 lacks
amino terminus of the PHF1b but contains two plant
homeodomains (PHD) with the remainder of the carb-
oxyl terminus. From the sizes of the clones and their
amino terminus sequences, it was predicted that the zinc
finger domain II with adjacent sequences is required for
DNA recognition. This zinc finger is characterized by a
C4HC3 motif and is found predominantly in proteins
that are associated with chromatin remodeling [35]. The
120 amino acid carboxyl terminal region adjacent to the
PHD finger II is predicted to form an HLH structure
[36] whereas the carboxyl terminus showed no signifi-
cant homology to any known structures. PHF1a, an al-
ternatively spliced version of PHF1 [37], shares an
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Figure 1 Results of a yeast one-hybrid assay using expressed human brain cDNAs and β1-INR sequences. A) The NLY2 yeast strain was
transformed to contain two integrated reporters (His3 and LacZ) (top panel) under the control of three tandem β1-INRs. This strain was used to
screen a yeast expression library containing cDNAs derived from human adult or fetal brains. cDNAs were expressed from a yeast 2 micron based
multi-copy plasmid with expression controlled by the ADH promoter. The libraries of expressed proteins contain a GAL4 activation domain (AD)
fused to each cDNA in frame to facilitate one-hybrid screening in yeast. Transformed yeast colonies were screened for their ability to grow on
selective solid media containing 10 mM 3-aminotriazole and lacking histidine. To confirm clone selection, expression of β-galactosidase was
measured by plating yeast colonies on plates containing chromogenic dye (X-gal). Purified clones are shown in relation to the wild type and full
length PHF1b (human Polycomblike protein) and PHF1a sequence. Two plant homeodomain (PHD) fingers are shown (I or II) with white boxes.
Black box represents the amino terminus. Different carboxyl termini that result from alternative splicing are shown with hatched (PHF1b) and
cross-hatched bars (PHF1a). A putative helix-loop-helix forming sequence is depicted by “HLH”. B) Screened candidates require INR sequence for
reporter gene activation. Top panel shows candidates A4 and B33 activates β-galactosidase reporter gene only when reporter promoter contains
the INR sequence. A reporter without INR sequence (bottom panel) shows no activity from the candidates in comparison to the vector plasmid.
Results are expressed as mean values ± SEM.
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terminus due to a frame shift that gives rise to two
unique ends of different sizes (Figure 1A, bottom panel).
Surprisingly, none of the candidates isolated were
PHF1a. A confirmatory experiment for INR site depend-
ency demonstrated that candidates A4 and B33 require
INR sequences for β-galactosidase reporter gene activity
(Figure 1B, top panel). Absence of the INR sequence in
this promoter/reporter construct does not support activ-
ity (Figure 1B, bottom panel).
PHD II and HLH are necessary for recognition of the β1-INR
PHD fingers are protein domains consisting of two zinc
ions coordinated by cysteine and histidine residues in a
C4HC3 motif [38,39]. Thus far, no specific function for
this motif has been identified, however, it has been pro-
posed that proteins containing PHD fingers are involved
in processes of chromatin remodeling [35].
To determine the minimum sequence of PHF1b ne-
cessary for INR recognition, a series of PHF1b trunca-
tion mutants were engineered (Figure 2). The GAL4
activation domain (AD) [40] was fused to zinc finger do-
mains I, II, and to the predicted HLH part of the protein
[36]. The DNA binding activity of these cDNA products
was tested in yeast. A number of cDNAs containingsequential deletions from the C-terminus were generated.
Expression of cDNAs encoding either PHD I, II or HLH
domains were not sufficient for DNA association as mea-
sured by growth on 10 mM 3-aminotriazole containing
media and ability to activate the β-galactosidase reporter
gene (Figure 2, rows 2, 3 and 4). A PHF1b fragment
that terminated at the divergent sequence with PHF1a
(Figure 2, row 8) [37] was also inactive. However, a longer
version of PHF1b (Figure 2, row 14) that included an add-
itional 40 amino acids beyond the putative HLH sequence
was sufficient for growth support mediated by the β1-INR.
Further sequential deletions defined the PHD finger II,
HLH, and a portion of the 40 amino acid domain (11
amino acid region) as being the required sequence for
INR recognition (Figure 2, row 10). The importance of the
11 amino acids (SFPSGQGPGGG) (glycine-rich motif)
was further tested in the context of either the PHD finger
II or HLH domain. The 11 amino acid sequence was fused
to the end of PHD finger II (Figure 2, row 6) and to the
HLH domain where the 11 amino acid sequence was im-
bedded in a larger sequence (Figure 2, row 5). Both fusion
proteins (rows 5 and 6) failed to support β1-INR recogni-
tion as measured by the yeast one-hybrid assay. Similarly,
the HLH alone was ineffective for INR recognition
(Figure 2, row 4).
Figure 2 Mapping sequences that are required for PHF1b DNA recognition. Depicted is the yeast strain with chromosomally integrated
reporters carrying three tandem β1 initiator sites that was used for one-hybrid assays. Candidates identified by one-hybrid assays were used to
construct a number of 5′ and 3′ sequential deletions of the PHF1b gene to define the minimal β1-INR binding domain. The GAL4 AD was fused
to all of the PHF1b fragments and tested for its ability to activate three tandem β1-INR sites linked to either His3 or LacZ. Full length PHF1b is
shown for comparison to relate relative sizes of AD fused PHF1b fragments (#2-14 with the exception of #9, which is a derivative of PHF1a) and
one-hybrid candidates B37 and A4. The DNA binding activities both positive (+) and negative (−) are as indicated. The criterion for DNA binding
is measured by the ability of the constructs to activate both reporter genes (His3 and LacZ ) at levels comparable to B37 and A4 isolates.
His3 expression was measured by the survival of the yeast colonies that could grow on plates that contained 10 mM 3-aminotriazole and
β-galactosidase activity from the second reporter, measured by β-galactosidase assays. The results from both assays were the same and are
indicated by one column to the right.
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HLH and the 11 amino acids beyond the frame shift point
of PHF1 proteins are essential for DNA recognition. The
significance of the glycine-rich 11 amino acid motif in the
context of the HLH domain is not clear. The alternatively
spliced version PHF1a does not contain the glycine-rich
sequence and does not bind β1-INR (Figure 2, row 9). The
minimum PHF1b DNA binder requires 11 amino acids
beyond the frame shift point of PHF1a (Figure 2, row 10).
It is plausible that the 11 amino acids of PHF1b may notbe essential for DNA binding but may be required for
some structural stability of the protein.
PHF1 proteins are localized to the nucleus
The larger Drosophila homolog of PHF1/PCL1 proteins
is localized in the nucleus [41], but the nuclear
localization motif has not yet been identified. To deter-
mine the region of PHF1b that contains the nuclear
localization signal, a number of truncated versions of
PHF1b were constructed (Figure 3) and fused to the
Figure 3 PHF1b deletion derivatives. PHF1b derivatives showing
amino terminus and carboxyl terminus deletions. These deletions are
used as GFP and GAL4(1–100) fusions to determine the nuclear
localization and repressor domains of the protein. Numbers represent
the amino acid positions that specify the sizes of the proteins.
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DNAs coding for GFP-PHF1b fusion proteins were
transfected into COS-7 cells that were fixed with para-
formaldehyde. The transfected cells were viewed through
a blue filter to detect the green fluorescence from the
hybrid proteins. PHF1b Δ6 (Figure 4D) is sufficient for
nuclear localization when compared with full length
PHF1b (Figure 4A) or other PHF1b derivatives that
contained amino terminus, PHD finger I and part of the
carboxyl terminus of the protein (PHF1b Δ1 and Δ5)
(Figure 4B and C). Taken together with the fact that the
GFP fusion protein with the amino terminus and PHDFigure 4 PHD domain II is necessary for the localization of PHF1b to
constructs (see Figure 3 for PHF1b deletion derivatives). Control representsFinger I (PHF1b Δ3) (Figure 4E) did not localize to the nu-
cleus, as compared with GFP alone (Figure 4F), the nu-
clear localization sequence (NLS) is most likely located
within the PHD finger II region and facilitates an associ-
ation with DNA by localizing the protein in the nucleus.
In addition to the COS-7 nuclear localization study,
we also investigated the localization of the same GFP-
PHF1b fusion proteins in primary rat neocortical neu-
rons (Figure 5). Results of confocal microscopy using
transfected neurons shows a similar pattern of PHF1b
expression as was observed with COS-7 cells. Full length
PHF1b (Figure 5D, PHF1b) is restricted to the nucleus.
Location of the nucleus was visualized by co-transfection
of cytomegalovirus (CMV)-DsRed-Nuclear (Figure 5E, H
and K). The PHD finger II domain is sufficient for nuclear
localization (Figure 5G, PHF1b Δ5). GFP alone (Figure 5A),
PHF1b Δ3 (Figure 5J) and DsRed-Monomer (Figure 5B)
are not restricted to the nucleus. As compared to COS-7,
the GFP-PHF1b expression pattern is highly restricted
within the larger neuronal nucleus (Figure 5D).
PHF1b stimulates GABRB1 promoter activity in transfected
primary cultured neurons
DNA alignment of the human, mouse, and rat β1 pro-
moters shows that the initiator sequence is identical and
the region 192-bp upstream and downstream of the initi-
ator is 94% similar (data not shown), suggesting that the
key regulatory factors for the promoter are conserved
across species. Considering the conserved nature of β1COS cell nuclei. COS cells were transfected with GFP-PHF1b fusion





Figure 5 PHF1b protein nuclear localization in rat neocortical neurons. Primary rat neocortical neurons isolated from E18 brain and
maintained one week in vitro were transfected with GFP-PHF1b fusion plasmids (CMV-GFP-PHF1b, CMV-GFP-PHF1b-Δ5, CMV-GFP-PHF1b-Δ3,
see Figure 3) and examined 48 hours after transfection by confocal microscopy for nuclear localization relative to DsRed-Nuclear marker
(CMV-DsRed-Nuclear), a red fluorescent protein that localizes to the nucleus. Control transfection of CMV-GFP (A, C) and CMV-
DsRed-Monomer (B, C) construct expression is throughout cortical cells and expression is not restricted to the nucleus (C). Both GFP-
PHF1b (D, F) and GFP-PHF1b-Δ5 (G, I) fusion construct expression coincides with DsRed-Nuclear (E, F and H, I) indicating that both the
PHF1b and the PHF1b-Δ5 protein contain a nuclear localization signal. In contrast, the GFP-PHF1b-Δ3 (J, L) fusion construct expression is
not restricted to the nucleus (DsRed-Nuclear, K, L) suggesting that the nuclear localization signal of PHF1b is not localized at the N-
terminus of the PHF1b protein. Scale bar is 10 μm.
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rat primary neuronal cultures is quite likely to be relevant
to gene regulation in humans. Towards this goal, an ex-
pression construct containing the human PHF1b cDNA
under control of the CMV promoter was co-transfected
into primary rat neocortical neurons to monitor the effects
of such expression on human GABRB1-p/luciferase re-
porter activity. There is a 3-fold stimulation of GABRB1
promoter activity observed upon PHF1b overexpression
(Figure 6), suggesting that PHF1b may be an important
regulatory factor of human GABRB1 transcription.Chronic GABA exposure regulates PHF1 binding to
endogenous Gabrb1
ChIP was used to demonstrate that PHF1 proteins are
bound to the endogenous rat Gabrb1 core promoter of
both hippocampal and neocortical neurons (Figure 7B)
where high levels of endogenous β1 subunit mRNAs have
been reported [7]. Binding of PHF1 to Gabrb1 is de-
creased after chronic treatment with GABA at a concen-
tration reported to down-regulate β1 mRNAs and subunit
levels in cultured neocortical neurons (Figure 7C and D).






























Figure 6 Transient transfection assays using primary rat
neocortical neurons. The human β1 promoter (475 bp) fused to a
luciferase reporter was co-transfected with an expression construct
for either full-length PHF1b or an empty vector. The CMV promoter
was used for PHF1b over-expression. (*) indicates significance of
(p < .05), Student’s T test. Results are presented as mean values ±
SEM (n=7). Luciferase counts were normalized to mg protein/dish.
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from Gabrb1 suggesting that the effects of GABA expos-
ure are through the GABAA receptor.
A PRC2 complex protein EZH2 requires PHF1a (Pcl1)
for efficient catalysis of (H3K27) trimethylation [42]. To
determine if PHF1b functions in this regard at Gabrb1, we
examined whether the trimethylation status of H3K27 is
altered at the core promoter region after GABA treatment.
No significant change in trimethylation at the H3K27 pos-
ition was detected, however, there was a 26% decrease of
monomethylation (n=6, p=0.0011) (Figure 8).
TAF1 and TAF2 as co-activators of PHF1b at the GABRB1
promoter
TAF1 and TAF2 contribute to DNA binding and core
promoter selectivity of RNA pol II [17]. It has been
shown that the complex formed by TAF1 and TAF2
preferentially bind to INR-like DNA sequences com-
pared to random DNA [21]. Independently, these two
TAFs do not show DNA sequence specificity, but as a
complex they recognize DNA and thereby recruit TFIID
to TATA-less promoters [21]. Since β1-INR showssignificant sequence similarity with the TdT-INR [13]
(see Figure 9A), we tested whether TAF1 and TAF2, per-
haps as a cofactor for PHF1b, would influence promoter
activity that is dependent on the β1-INR.
The transcriptional start site from β1-INR was ana-
lyzed in the context of a synthetic GAL4 upstream acti-
vating sequence (UAS) (Figure 9B). Promoter activity of
this construct (p5XG-β1-INR-Luc construct) was signifi-
cantly reduced in COS-7 cells when compared to a con-
struct that contained the adenovirus E1B TATA instead
of β1-INR [43] (data not shown). This result is to be
expected given the fact that the TATA-less promoters
are in general weaker than TATA-containing promoters
[12] and β1-INR is derived from a neural specific gene.
In order to determine whether transcription initiated
from the synthetic promoter through the β1-INR, total
RNA was prepared from COS-7 cells that had been co-
transfected with the expression construct for the GAL4-
VP16 activator and p5XG- β1-INR-Luc. Primer exten-
sion analysis showed two major transcripts originating
from use of the synthetic promoter (Figure 9C). The
start sites we identified are different from those observed
by Russek et al., [7], but both originate within the se-
quence of β1-INR. This discrepancy of start sites is most
likely due to the fact that the two promoters are struc-
turally different from each other, one being in the ori-
ginal human GABRB1 promoter, studied in neurons, and
the other containing only the β1-INR element in the
context of GAL4 UAS, studied in COS-7 cells.
The p5XG-β1-INR-Luc construct was also used in co-
expression studies with either TAF1 or TAF2 and PHF1b
to study the effect of TAF co-activator properties on
promoter activation. Again, the GAL4-VP16 construct
was used to express the common upstream activator
that recognizes the GAL4 UAS for these experiments
(Figure 9B and D). Over-expression of PHF1b shows en-
hancement of luciferase activity with greatest effect in
the presence of either TAF1 or TAF2 (Figure 9D).
PHF1b over-expression potentiates TAF co-activity two
to three fold. Moreover, co-expression of TAF1 and
TAF2 with PHF1b increases the activity of the p5XG-β1-
INR-Luc promoter as much as six fold compared to acti-
vation with the GAL4-VP16 activator alone.
PHF1b represses transcription from the TK promoter at a
distance
In order to study transcriptional properties of various
PHF1b domains the protein domains were individually
fused to the GAL4 DNA binding domain and tested. A
synthetic promoter containing the GAL4 UAS and the
TK enhancer promoter was employed to test whether
PHF1b could function as a repressor or activator from a
distance. GAL4-PHF1b fusion constructs were co-
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Figure 7 Association of PHF1 proteins with endogenous Gabrb1 in neurons. ChIP assays were performed using a PHF1(a and b) specific
antibody and precipitated genomic DNA was found to contain the core promoter region of Gabrb1 in primary rat neocortical neurons. Detection
of the endogenous Gabrb1 promoter was accomplished by PCR as depicted in (A) using two primers (arrows) that flank the β1-INR. The size of
the PCR fragment is indicated above. Initiator position is depicted with a box and arrow showing the direction of transcription. (B) Bottom panel
shows the presence or absence of Gabrb1-specific PCR products in fragments of genomic DNA that have been precipitated after addition of
PHF1 antibodies. ChIP substrates are as indicated (1) primary neocortical neurons and (2) primary hippocampal neurons cultured for 7 days from
E18 rat brains. (C) Representative data showing the presence or absence of Gabrb1-specific PCR products from ChIP performed with PHF1
antibody. Primary neocortical neurons were treated with either GABA (500 μM), GABA and the specific GABAAR antagonist bicuculline (50 μM),
bicuculline alone, or relevant vehicle for 48 h, as described in Russek et al [7]. Presence of IgG in reaction is represented as “-“ and PHF1 antibody
as “+”. (D) Quantitation of ChIP data displayed in (C) is represented as mean ± SEM and expressed as percent increase from control (% control).
(*=significantly different from control, p < 0.05). All samples were analyzed as ratios of PHF1 antibody/IgG after normalization to input.
A
B
Figure 8 GABA decreases H3K27 mono methylation on the Gabrb1 promoter. Real time PCR analysis of ChIP assays show a statistically
significant (***) decrease (n=5) of H3K27 monomethylation at the core promoter region (P = 0.0001) (A) with no significant change in the status
of trimethylation (n=5, p=0.1184). Y-axis represents relative signal of H3K27 (mono- or tri-) methylation as compared to vehicle control (set as 1).
A Student’s t-test was used to investigate the statistical significance of mono- and trimethylation. (B) Radiographic display showing amplified
promoter fragments immunoprecipitated with H3K27me1 (mono) and H3K27me3 (tri) antibodies. Total input DNA and IgG lanes are marked by
“TOT” and “-“, respectively. Results are expressed as mean values ± SEM.




Figure 9 Study of the β1-INR in COS cells. A) Sequence similarities between β1-INR, TdT INR and the adeno-associated virus (AAV) P5+1 INR.
Shadowed boxes highlight sequence identity. Arrows indicate transcription start sites. Star symbol indicates the major start site of β1-INR in neocortical
neurons (7). B) Depiction of a TATA-less synthetic promoter/reporter construct carrying a single β1-INR with a GAL4 UAS (p5XG-β1-INR-Luc). Promoter
activity of the construct is regulated by co-expression of an upstream activator (GAL4-VP16). Arrows show the direction of transcription. C) Primer
extension analysis of RNA from COS-7 cells transfected with the p5XG-β1-INR-Luc construct. Primer extension products are separated on a sequencing
gel. Sequencing reactions (dC and dT) were run alongside of primer extension products to determine the exact start sites for initiation. Top strand DNA
sequence of β1-INR is also shown next to sequencing lanes. Arrows indicate the major initiation sites in COS-7 cells. D) Co-activation of PHF1b
transcriptional activity by TAF1 and 2. COS-7 cells were co-transfected with p5XG-β1-INR-Luc, GAL4-VP16 and combinations of PHF1b, TAF1 and TAF2.
48 hours after transfection, cells were harvested and assayed for luciferase activity. Results shown are mean values ± SEM and normalized to protein
content within each dish as well as to vector control (Vector+Vector+GAL-VP16 defined as 100%). “*” indicates significantly different from vector
control (p < 0.05) as determined by 95% confidence interval. “#” indicates significantly different from PHF1b (Vector+PHF1b+GAL-VP16) (p < 0.05) as
determined by 95% confidence interval.
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recruited 200-bp upstream of the TK enhancer promoter
at the GAL4 UAS (Figure 10) and luciferase reporter ac-
tivity was measured. As seen in Figure 10, full length
PHF1b fused to GAL4 functions as a strong repressor of* *
*























































Figure 10 Investigation of transcriptional repression using a panel of
PHF1b versions fused to GAL4 (1–100) were recruited upstream of the TK enha
(pG5-200tkLUC). GAL4 (1–100) contains the DNA binding domain that recogni
CMV promoter. COS-7 cells were co-transfected with the reporter plasmid (pG5
cells were harvested and assayed for luciferase activity. Results shown are mean
well as to vector control (pG5-200tkLUC+ GAL4 (1–100) defined as 100%). “*” in
by 95% confidence interval. B) GAL4-PHF1b fusion proteins are expressed in CO
transfected or expressing PHF1b constructs were analyzed by Western analysis
cells (1) and proteins were detected for cells transfected with PHF1b (2), PHF1bthe TK enhancer promoter from a distance. To delineate
the minimum domain required for repression, we tested
both amino and carboxyl terminus deletions of PHF1b
(Figure 3). A fusion protein containing both PHD fingers
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B
GAL4-PHF1b fusion proteins. A) Full length PHF1b and truncated
ncer promoter which was linked to a luciferase reporter gene
zes GAL4 regulatory sites. GAL4-PHF1b fusions were expressed from a
-200tkLUC) and the constructs as indicated. 48 hours after transfection,
values ± SEM and normalized to protein content within each dish as
dicates significantly different from vector control (p < 0.05) as determined
S-7 cells as shown by Western analysis. Extracts of COS-7 cells mock
using a GAL4 antisera. No proteins were detected in mock-transfected
Δ4 (3), PHF1bΔ3 (4), PHF1bΔ6 (5). Molecular size markers are to the right.
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that each PHF1b PHD finger contains a potent repressor
domain (Figure 10, PHF1b Δ3 and Δ6). Interestingly, de-
letion of the amino terminus with PHD finger I abol-
ishes the repressive function of PHF1b (Figure 10,
PHF1b Δ4). The expression levels of these transfected
GAL4-PHF1b fusions are relatively similar in COS-7
cells and confirmed with immunoprecipitation analysis
by using GAL4 antibodies (Figure 10B).PHF1b co-immunoprecipitates with SUZ12, a PRC2
associated protein
In the PRC2 complex fraction, purified from HeLa and
293F cells, PHF1a is associated with PRC2 proteins
[42,44]. We now asked whether neuronal PHF1b would
also be part of PRC2 by determining whether it associates
with any of the key proteins of the PRC2 complex. The
SUZ12 antibody was chosen for co-immunoprecipitation
analysis because this protein is an integral member of the
PRC2 complex and because SUZ12 affinity columns have
been successfully used to isolate EZH2-EED complexes
found in the HeLa cell extract [44]. In the PHF1 immuno-
precipitate, upon Western blot, the larger alternatively
spliced isoform b of PHF1 is detected (see Figure 1, com-
pare PHF1a and PHF1b) (Figure 11 A, lane 1 and 3).
PHF1b is also the predominant isoform detected by stand-
ard Western analysis in rat neocortical neurons (Figure 12,
panel 6). In the SUZ12 immunoprecipitate, PHF1b is
detected (Figure 11A, lane 5) and likewise in the PHF1A B
Figure 11 PHF1 and SUZ12 are co-immunoprecipitated from
primary neocortical neurons, as shown by Western blot. Primary
E18 cortical neurons, maintained seven days in culture, were lysed
and immunoprecipitated (IP) with PHF1 (A lane 3, B lane 3), SUZ12
(A lane 5) and pre-immune (A lane 2, lane 4, B lane 2) antisera.
Immune complexes were separated by sodium dodecyl sulfate
polyacrylamide gel electrophoresis (SDS-PAGE) and transferred to
nitrocellulose. PHF1 (A) or SUZ12 (B) proteins were identified by
immunoblotting with either PHF1 (A) or SUZ12 (B) antisera. The
molecular weight markers are shown to the left.immunoprecipitate, SUZ12 is detected confirming a po-
tential association between the proteins in neurons
(Figure 11B).
PHF1 proteins are highly expressed in the rat brain
Although PHF1a was present in the library, we did not
identify PHF1a as a β1-INR associating factor in yeast one-
hybrid assays, even though it contains significant hom-
ology to the INR binding domain of PHF1b (Figure 2).
Thus, it was hypothesized that the levels of PHF1a might
differ from PHF1b in neurons. To understand whether
there is a significant difference in the levels of alternatively
spliced versions of PHF1, a PHF1 antibody was generated
against a 20 amino acid peptide sequence that is common
to both PHF1 isoforms (see Methods). Western blot ana-
lysis using the PHF1 antibody was then performed with
nuclear extracts derived from primary cultured E18 rat
neocortical neurons and adult rat brain. Two distinct pro-
tein bands of sizes 45 kD (PHF1a) and 60 kD (PHF1b)
were observed (Figure 12, panel 6) with PHF1b being the
predominate splice variant.
Given the fact that many GABAA receptors in the hip-
pocampal formation are believed to contain β subunits
[45], adult rat brain tissue was examined for the presence
of PHF1 protein in regions where β1 subunit expression is
expected to be high. Slices (Bregma –6.3mm) were stained
with a PHF1 antibody as described above and in Methods.
Hippocampal neurons show marked levels of PHF1 ex-
pression in the CA1 region, as well as the dentate gyrus
(Figure 12, panels 2 and 3). PHF1 expression was also
detected in the neocortex (data not shown).
Discussion
A human Polycomblike protein was discovered that as-
sociates with the initiator of the core GABRB1 promoter.
The PHF1b PHD zinc finger domain (C4HC3), HLH
structure and the glycine-rich motif (SFPSGQGPGGG)
of this protein are sufficient for specific DNA association
at β1-INR. Importantly, this discovery of a Polycomblike
protein as a potential DNA recognition molecule for in-
hibitory receptor subunit expression sheds light on the
important role of Polycomb group (PcG) proteins, whose
mechanism for developmental regulation of transcrip-
tion remains unknown [31,33,46]. In addition, our re-
sults may explain how the PcG/trxG complexes could be
recruited to specific DNA sequences through protein-
DNA interactions. PcG proteins were initially identified in
Drosophila as proteins that are involved in maintaining
the repression of homeotic genes necessary for anterior-
posterior development [47]. PcG and trx-G are required
for the maintenance of homeotic gene expression after the
degradation of the gap and pair-rule proteins [47]. TrxG
maintains expression of homeotic genes, whereas PcG fac-
tors maintain their repression [31].
Figure 12 Immunodetection of PHF1 proteins in nuclear extracts of primary rat neocortical cultures and slices of adult rat
hippocampus. Western analysis of PHF1a and PHF1b expression using nuclear extracts of rat neocortical neurons and a primary antibody raised
against a PHF1 peptide present in both PHF1a and PHF1b (panel 6). Relative size of PHF1 proteins is as indicated using relationship of migration
pattern of putative PHF1a and b to position of marker proteins. Adult rat brains were sectioned coronally at Bregma −6.3mm (as depicted in
panel 1) and treated with a primary antibody to PHF1 as described above. Positive immunostaining is indicated by brown-black precipitates
(panel 2 and 3). Regions of CA1 (field CA1 of hippocampus), DG (dentate gyrus) and PoDG (polymorph layer dentate gyrus) are indicated as
references. Panel 2 displays high PHF1 immunoreactivity in the CA1 region. Arrow in panel 2 indicates area of CA1 region that was magnified
(100×) in the display of panel 3. A dark scale bar at the bottom of panel 3 shows the virtual distance between two points. Hippocampal slices
processed in parallel to the experimental were treated with the PHF1 antibody blocking peptide and secondary antibody (shown in panel 4). A
representative hippocampal slice processed in parallel treated only with the secondary antibody is displayed in panel 5 as an additional control.
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Proteins containing PHD finger motifs are believed to
drive chromatin remodeling [35] by affecting protein-
DNA or protein-protein interactions. Recent reports con-
tributed to our understanding of how this domain might
function in the context of some well-characterized pro-
teins. For example, acetyltransferase activity of CBP
(CREB binding protein) is dependent upon an intact PHD
finger [48]. Another report [49] has shown that ING2, a
PHD protein and a putative tumor suppressor protein,
binds to phosphoinositides (PtdinsPs) through its PHD
finger domain. The PHD finger of ING2 is a PtdinsPs nu-
clear receptor and is involved in nuclear responses during
DNA damage. Interestingly, we find that PHF1 (variants a
and b) is a nuclear protein with nuclear localization deter-
mined by the PHD finger II (Figures 4, 5).PHF1b may represent a different class of PtdinsPs nu-
clear receptor proteins that are also capable of specific
DNA binding. Our DNA association studies show that
the PHD finger II is not sufficient for DNA association
on its own, but requires another adjacent 131 amino
acid region, capable of forming a HLH [36]. Apart from
containing the NLS, it is not clear how the PHD finger
II contributes to the overall binding of DNA. Whether
the PHD finger or the HLH motif of PHF1b makes con-
tact with the β1-INR-DNA remains to be determined. It
is possible that the PHD finger itself may not be physic-
ally required for DNA binding but essential for modulat-
ing PHF1b’s DNA binding recognition. Alternatively, we
propose that PHD fingers may provide initial DNA se-
quence recognition by helping interaction with nucleo-
somes. A similar hypothesis has been proposed by
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finger in the context of a bromodomain. The authors
show that both the bromodomain and PHD finger re-
gion of p300 are required for binding of acetylated nu-
cleosomes in vitro. In this context, the PHD finger is
thought to function as a co-recognizer of the nucleo-
somes or as a stabilizer of the bromodomain.
The functions of PcG and trxG proteins are mediated
by overlapping Polycomb/Trithoraxgroup response ele-
ments (PRE/TRE) [31,51,52]. The mechanism behind
target recognition of these sites still remains to be deter-
mined. Among the family of PcG and trxG, only three
members have been shown to have specific DNA bind-
ing functions. PcG member PHO (a YY1 homolog) and
two trxG proteins named GAGA and Zeste bind specific
DNA sequences [53-57]. Our results suggest that PHF1b
is another specific DNA binding protein of the PCL fam-
ily that may function in a novel manner to recruit the
PcG and trxG complexes to an INR sequence for effect-
ive control over pre-initiation complex formation at the
core promoter region.
Results of PHF1b overexpression also show that acti-
vation of the human GABRB1 promoter or a synthetic
promoter containing a single β1-INR can be positively
regulated by PHF1b (Figures 6 and 9D). This is a sur-
prising result given that PcG proteins are usually associ-
ated with transcriptional repression. It is intriguing that
PHF1b can function as a positive and negative modula-
tor of transcription in a manner similar to the function
of the YY1 protein [23,58]. The positive or negative na-
ture of YY1 regulation is also thought to be context
dependent and achieved through the interactions with
specific modulatory factors [58]. PHF1a/PHF1b and YY1
protein both share zinc finger domains required for
DNA binding [26]. Interestingly, the β1-INR is also simi-
lar to the core portion of the AAV P5+1 INR [26] pro-
moter that is bound by YY1 (see Figure 9A). It remains
to be determined whether these two initiator recognition
proteins may recognize one another’s binding sites to re-
cruit different PcG complexes. The fact that YY1 has been
implicated in gene regulation of neurons [59] and that
Gabrb1 is expressed early on in the germinal matrix of the
embryonic rat nervous system [60] and in the adult rat
brain [45], suggests that there may be a relationship
between PHF1b and YY1 regulated transcription.
Both Drosophila PCL and PcG protein YY1 [61] inter-
act with the mammalian members of RPD3 family of
HDACs [62,63], suggesting an involvement in chromatin
remodeling. Apart from being an INR binding protein,
YY1 is also expressed in the Xenopus anterior neural
tube during tailbud stage in embryos. Inhibition of Xen-
opus YY1 function resulted in embryos with antero-
posterior axial patterning defects similar to over expres-
sion of XenopusPcG genes XPCL1/2, Xbmi1 and XEZ[64-67]. Results of our GAL4-PHF1b fusion protein
studies show that PHF1b is a strong repressor when
recruited at a 200-bp distance from the TK enhancer
promoter (Figure 10A). Repression by the PHF1b fusion
protein is similar to that reported for the GAL4-YY1 fu-
sion protein [23].
PHF1b-mediated repression is conferred by two PHD
fingers that are also capable of repressing individually
when they are fused to the GAL4 DNA binding domain
(Figure 10; PHF1 Δ3 and Δ6). It has been shown that
two PHD fingers of Drosophila Polycomblike protein are
the target sites for RPD3 (histone deacetylase) inter-
action [62], which is consistent with our results where
the repressive function of PHF1b is lost after deletion of
the amino terminus of PHF1b containing the PHD fin-
ger I domain (Figure 10A; PHF1 Δ4).
The alternatively spliced version of PHF1, PHF1a, has
been found to be associated with Enhancer of Zeste,
EZH2 [42,44,68] to catalyze H3K27 trimethylation,
which is essential for the maintenance of the repressive
chromatin status of the HoxA gene [42]. The authors
also found that the GAL4-PHF1b fusion protein is a
strong repressor when it is recruited upstream of a TK
promoter reporter gene. Unlike PHF1b, PHF1a has not
been shown to bind any particular DNA sequence. Our
results suggest, however, that neuronal PHF1b through
its recognition of the β1-INR may play an active role in
stabilizing gene transcription rather than repression,
consistent with a recent prediction for PHF1b inter-
action with the ATP-dependent chromodomain helicase
DNA binding protein (CHD4) [69,70]. CHD4, when it is
outside of the NuRD repressor complex, can function as
an activator of transcription in association with p300
histone acetyltransferase [71].
Our results suggest that this may also be the case for
PHF1b which immunoprecipitates with SUZ12, a key
component of the repressive PRC2 complex (see
Figure 11). In our studies, loss of PHF1b from Gabrb1-p
(as measured by ChIP) is associated with a decrease in
Gabrb1 mRNA levels [34] and a decrease in monome-
thylated H3K27, without a subsequent increase in
trimethylated H3K27 (Figure 8B). This finding suggests
that either the monomethylated form may be uniquely as-
sociated with PHF1b binding to initiators or that there is
an increase in di- and trimethylation that we have not yet
detected with ChIP analysis. Recent studies of PHF1, and
several other related genes, have revealed that PcG gene
products can also be found associated with histone H3
trimethylated at lysine 36 (H3K36me3), a chromatin mark
linked to transcriptionally active genes. These results sug-
gest that the PCL family of proteins may facilitate recruit-
ment of PcG proteins to previously active genes, leading
to de novo gene silencing [72]. We are currently pursu-
ing these studies in the laboratory to gain a better
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system and its potential generalizability to the regulation
of other gene products critical for brain development and
disease.
From our studies, and taken together with the function
of YY1 described above, we propose that binding of
unique PcG factors such as PHF1b to the INR may be a
key element to dynamically attract the chromatin re-
modeling machinery to the initiation site of a gene. It is
here where stabilization of the pre-initiation complex is
so critical for modulating rates of transcription. Unlike
cells in many other regions of the body, in neurons small
changes in the expression of membrane receptor pro-
teins can have far-reaching effects on the activity of
neural networks. Taken together with the finding that
GABAergic excitation promotes differentiation of hippo-
campal progenitor cells [73], identification of a potential
relationship between chromatin remodelers, receptor ac-
tivation, and the transcription and/or repression of cer-
tain neurotransmitter receptor subunit genes opens a
new area of investigation that may be extremely relevant




PHF1(a and b) antibody (rabbit polyclonal) was raised
against the peptide RPRLWEGQDVLARWTDGLLY by
Research Genetics, Inc (Huntsville, AL, USA). Antibody
against H3K27me1 (Cat No. 07–448, rabbit polyclonal)
was purchased from Upstate (Millipore) (Billerica, MA,
USA). H3K27me3 (Cat No. ab6002, mouse monoclonal))
and SUZ12 (Cat No. ab12073, rabbit polyclonal)) anti-
bodies were obtained from Abcam Inc (Cambridge, MA,
USA). A 1–200 to 1-500 dilution of antibodywas used
for immunoprecipitation experiments. For Western ana-
lysis, a 1–1000 to 1-3000 dilution of antibody was used.
Chemicals
3-aminotriazole and GABA were purchased from Sigma-
Aldrich (St. Louis, MO, USA). Yeast and tissue culture
media were obtained from Invitrogen (Grand Island,
NY, USA).
His3 Screening
The NLY2 strain of yeast carrying two integrated re-
porter genes (His3 and LacZ) was grown in YPDA media
to make competent cells according to [74]. Forty μg
of adult or neonatal human brain cDNA library
(Clontech, constructed from 6X106 individual bacterial
colonies) was transformed into competent yeast
plated on minimal media (His-, Leu-) containing 10 mM
3-aminotriazole. Approximately 500 colonies were iden-
tified from the primary screen and tested for β-galactosidase gene expression on X-gal containing plates.
Blue colonies were isolated for further analysis in His3
growth screens. Plasmids that were recovered from both
screens were transformed back into the original yeast
strain to test plasmid linkage. A control experiment was
also performed in yeast to verify that the DNA binding
property of PHF1b (Genebank accession: BC008834)
containing clones was specific to the β1-INR. A chromo-
somally integrated reporter (lacZ) gene without the β1-
INR showed no activation from expression of isolated
PHF1b (data not shown).
β-galactosidase activity
β-galactosidase activity and X-gal plate assays were
performed as described in [75]. DNA sequencing was
performed at the Boston University School of Medicine
Genetic Core facility. Yeast strain NLY2 (gift of Dr. N.
Lehming) (MATa Δgal4, gal80, ura3-52, his3-200, leu2-3,
trp1, lys2) was used to integrate two reporter-carrying
plasmids in yeast chromosomes. Reporter plasmids were
constructed with two separate yeast-integrating vectors
that carried Trp1 and Ura3 genes for chromosomal inte-
gration. A fragment containing three tandem initiator
sites (TCGACTGCGCAGGTCCATTCGGGAAT TACT
GCGCAGGTCCATTCGGGAATTA CTGCGCAGGTC
CATTCGGGAATTAC) was inserted 40 nucleotides up-
stream of Gal1 and His3 TATA boxes. To determine the
DNA binding function of PHF1b, the deletion constructs
were made with pACT2 based candidate plasmids A4
and B37. PFU polymerase amplified PHF1b fragments
were inserted into NcoI and XhoI restriction sites of the
backbone vector. CMV-PHF1b was constructed by
inserting full length human PHF1b cDNA in between
Nhe1 and Xho1 sites of pCI-neo Vector (Promega).
GABRB1-luciferase was previously described in [7].
5XGAL4-INR-LUC is a derivative of the pGL2 vector
(Promega). A fragment containing a single initiator with
five upstream Gal4 sites was inserted in between the
SmaI and BglII sites of pGL2. GAL4-VP16 expression
was driven by a SV40 promoter and is described in [76].
CMV-DsRed-Nuclear and CMV-DsRed-Monomer were
obtained from Clontech for nuclear localization studies.
CMV-TAFII250 was a generous gift of Dr. R. Tjian.
T7-TAFII150 [77] was a generous gift from Dr. R. G.
Roeder and was converted to a CMV-TAFII150 with an
insertion of the CMV promoter fragment (blunted BglII-
SmaI). GFP fusion plasmids were constructed by
inserting GFP (NheI-SalI) in between the CMV pro-
moter and the PHF1b derivatives depicted in the figure.
GAL4(1–100)/PHF1b fusions were constructed in a
similar way by inserting the GAL4(1–100) fragment into
the NheI and SalI sites between the CMV promoter and
PHF1b fragments. All plasmids were confirmed by
sequence analysis.
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Primer extension analysis of the p5XG-INR-LUC plas-
mid containing the β1-INR was performed according to
[40]. A luciferase specific primer (5′-CCATCCTCTAGA
GGATAGAATGGC GCCGGG-3′) was used for primer
extension analysis. Total RNA was isolated from
transfected COS cells containing the p5XG-INR-Luc
plasmid and GAL4-VP16 activator plasmid for analysis.
Chromatin IP
ChIP assays were performed as previously described [78].
Five to 10 million cells were used for each assay and were
split into three aliquots for immunoprecipitation in the
presence and absence of PHF antibodies (200 × dilution).
Genomic DNA (gDNA) was sheared to produce fragments
of 300–500 bps. Average size was verified by agarose gel
electrophoresis. Immunoprecipitatedg DNAs were isolated
and dissolved in 100 μL TE to be used as templates for
PCR amplification of a 213-bp fragment of the GABRB1
promoter that contains the PHF1b binding site (β1-INR).
Primers 5′-AAGGGATTGAAATCTGTTGCCTG-3′ (β1-
forward) and 5′-CCAAACTCTCTCGATTTTGTACT-3′
(β1-reverse) (rat β1: Genebankaccession: AC114826). 35S-
labeled PCR products were separated on a 5% polyacryl-
amide gel and exposed to X-ray film (Kodak). PCR was
also performed on gDNAs precipitated with rabbit IgG
(Santa Cruz) as a negative control that was used for
normalization. Figure 7C PCR detection was performed
without radioactive isotope. Real-time PCR analysis
(Figure 8) was performed using primers and probe
designed with SciTools (IDT). GABRB1-p primers: sense
(5′- TGTTTGCAAGGCACAAGGTGTC -3′), antisense
(5′-TCTGCGAAGATTCAAGGAATGCAACT -3′); probe:
5′FAM- TCCATTCGGGAATTACTGCCCAGCCGCCGA
-TAMRA3′. Thermocycling was done using the ABI7-
900HT in a final volume of 20 μL. PCR parameters were
50°C for 2 min, 95°C for 15 min, 50 cycles of 95°C for 15 s,
and 60°C for 1 min. Standard curves were generated from
rat gDNA (Clonetech). Data were normalized as percentage
of antibody/IgG signal after adjustment to input.
Culturing and transfection of primary rat neocortical neurons
Primary cortical and hippocampal neurons were derived
from 18-day rat embryos and grown in media as de-
scribed [7]. Cells were plated on 100 mm tissue culture
dishes (1.33 brains per dish). The plating medium was
replaced by a serum-free conditioned medium after one-
hour incubation. Cultures were maintained for 7–9 days
before being used for transfections or ChIP experiments.
Primary cell cultures were transfected using a modified
calcium phosphate precipitation method [79]. Briefly,
DNA and CaCl2 was mixed with HeBs (137 mM NaCl, 5
mM KCI, 0.7 mM Na2HPO4, 7 H2O, 7.5 mM dextrose,
21 mM HEPES, pH 7.14) and stored in the dark at roomtemperature for 25–30 min. Cultures were washed twice
with DMEM (Invitrogen, Rockville, MD) and 250 μL of
a DNA precipitate were added to each dish. CMV-
PHF1b or CMV-vector DNA (10 μg) were transfected
into each 100 mm dish (Nunc) with 5 μg of the
GABRB1-luciferase promoter/reporter construct. Cul-
tures were harvested and luciferase activity was mea-
sured [80].
Cell culture, transient transfection of COS-7 cells,
fluorescent and confocal microscopy
COS-7 cells were grown in DMEM, penicillin/strepto-
mycin, 10% fetal bovine serum (FBS), and 2 mM glutam-
ine. COS-7 cells were grown to confluency in T flasks
and treated with trypsin/EDTA. The cells were treated
with 10 ml of media and seeded at 2X105/plate. After
seeding (24 h), COS-7 cells were transfected using the
FUGENE transfection reagent (Roche). 1.2 μl FUGENE/
1 μg of DNA was used for each transfection. The expres-
sion of all plasmids used in our transfection studies was
compared by Western analysis to control for nonspecific
differences in functional assays that might be due to
DNA quality or size of insert. Amount of DNA used in
transfection assays was also based on moles rather than
μg of vector DNA. After 48 hours, cells were assayed for
luciferase activity (Promega kit and Victor 1420 detec-
tion system (Wallac)) or visualized with fluorescent
microscopy. Luciferase counts were normalized indepen-
dently to either total protein content or CMV-βgal activ-
ity. To prepare the cells for fluorescent microscopy, the
plates were incubated 15 min in fixing solution: 4% para-
formaldehyde, 25 mM HEPES, 150 mM NaCl, 1 mM
CaCl2, and 1 mM MgCl2, washed 3× in PBS and then in-
cubated in a quenching solution (PBS/50 mM NH4) for
10 min. A PBS wash followed quenching. The cells were
permeabilized with PBS/1% Triton X-100 for 5 min
followed by a PBS wash. Transfected COS-7 cells were vi-
sualized using a fluorescent microscope (Zeiss Axioscope)
and photographed using slide film (Kodak Elite II 400).
Cells for confocal imaging were plated on glass coverslip
dishes (MatTek Corp). Images of primary neurons were
acquired using a Zeiss Axiovert 100M laser scanning con-
focal microscope with a C-Apochromat 40×/1.2 water
immersion objective and an optical depth of 1 μm. An
argon laser was used to detect GFP and a helium-neon
laser was used to detect DsRed. The photomultiplier gain
and pinhole aperture were kept constant.
Immunoprecipitation
Cortical cells were rinsed twice in ice-cold PBS and lysed
in ice-cold lysate buffer (1% (v/v) Nonidet P-40, 0.1% (w/v)
sodium dodecyl sulfate (SDS), 10% (v/v) glycerol, 50 mM,
Tris HCl, pH 8, 150 mM NaCl with protease inhibitors
(Roche)). Cell lysates were cleared by centrifugation
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overnight with specific antibody or pre-immune serum.
Then, protein A Sepharose beads were added for 2 hours.
The beads were washed three times with lysate buffer and
once with water. Proteins were eluted by boiling in sodium
dodecyl sulfate polyacrylamide gel electrophoresis (SDS/
PAGE) loading buffer and separated by SDS/PAGE before
Western blotting.
Animal care
Adult male Sprague–Dawley rats (250-300 g) were pur-
chased from Taconic Farms (Germantown, NY, USA)
and housed individually with water and food available ad
libitum. A 12-h light/dark cycle was maintained and all
experiments were performed during the light cycle. All
protocols were consistent with the guidelines of the
National Institutes of Health and were approved by the
Boston University School of Medicine Institutional Ani-
mal Care and Use Committee.
Tissue collection, sectioning and antibody staining
For immunohistochemistry, rats were euthanized with
100 mg/kg pentobarbital (i.p.). The animals were then
perfused through the heart with 120 ml of 0.9% saline
followed by 60 ml 2% paraformaldehyde in 0.1 M PBS,
pH 7.3. The brains were removed and further fixed in
2% paraformaldehyde for 48 h at 4°C. Thirty-micron cor-
onal serial sections were obtained using a vibratome
(Energy Beam Sciences, Agawam, MA, USA) and placed
in PBS until being processed by single-label immunohis-
tochemistry. Brain sections were incubated in 4% normal
rabbit serum (Jackson ImmunoResearch, West Grove,
PA, USA) diluted in PBS for 45 min to prevent
nonspecific binding. The sections were incubated over-
night in primary rabbit antibody (PHF1) diluted 1:500 in
PBS at 4°C. The incubation was followed by a 30 min
wash in PBS. The sections were then incubated for 2 h
in biotinylated goat anti-rabbit IgG (Vector Laboratories,
Burlingame, CA, USA) diluted 1:500 in PBS. The sec-
tions were rinsed in PBS for 30 min, followed by incuba-
tion in avidin-biotin-peroxidase reagent (30 min) (ABC
Elite; Vector). A final rinse in PBS preceded treatment
with diaminobenzidine tetrachloride (DAB) containing
H202 and nickel-enhancing solution for 10 min. Sections
were mounted using slides and Slow Fade mounting
media (Molecular Probes, Eugene OR, USA). Control
sections were processed as described but without pri-
mary antibody or in combination with 5-fold excess of
PHF blocking peptide for 2 hours before immunohisto-
chemistry was performed.
Western blot analysis
Nuclear extract made from primary rat neocortical neu-
rons [80] was electrophoresed on a 10% SDS-PAGE geland transferred to a Biorad nylon filter (PVDF type) for
Western blot analysis. The filter was probed with PHF1
antibody (1:3000 dilution) and the analysis was performed
[81]. Immunoprecipitation of GAL4 fusion proteins was
visualized using a polyclonal antibody raised against the
GAL4 DNA binding domain (amino acids 1–147). GAL4
antibody was a kind gift Dr. Mark Ptashne.
Conclusions
We have demonstrated that the Polycomblike protein
PHF1b binds to β1-INR to stimulate transcription, and
that chronic exposure to GABA reduces PHF1 binding
and H3K27 monomethylation associated with transcrip-
tional activation. This strongly suggests that PHF1b, a pro-
tein involved in homeotic gene expression in Drosophila,
may be a molecular transducer of GABAAR function and
thus a component of GABA-mediated neurotransmission
in the human central nervous system. We have also shown
that PHF1b recognition of β1-INR is dependent on a plant
homeodomain, an adjacent helix-loop-helix, and short
glycine rich motif, and we propose that binding of PHF1b
to β1-INR represents a critical step in chromatin remodel-
ing that may be necessary for the modulation of certain
forms of transcription. Given that the GABAAR contains
recognition sites for a variety of agents used in the treat-
ment of a range of brain disorders, we suggest that add-
itional research into the role of PHF1b in the regulation of
gene expression in neurons may potentially lead to the
development of novel treatments for neurological and
neuropsychiatric diseases such as epilepsy and anxiety.
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